Global Secondary Hyperparathyroidism Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

SKU ID : GIR- 12611605

Publishing Date : 16-Nov-2018

No. of pages : 120

PRICE
3480
6960

  • Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands.

    Scope of the Report:
    In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting.
    The global Secondary Hyperparathyroidism Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Secondary Hyperparathyroidism Treatment.
    Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
    This report studies the Secondary Hyperparathyroidism Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Secondary Hyperparathyroidism Treatment market by product type and applications/end industries.

    Market Segment by Companies, this report covers
    Amgen
    OPKO Health
    AbbVie
    Astellas Pharma
    Roche
    KAI Pharmaceuticals
    Kyowa Hakko Kirin
    Leo Pharma
    Shire
    Sanofi
    Deltanoid Pharmaceuticals

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Surgery
    Drugs
    Vitamin D
    Calcimimetics
    Phosphate Binders

    Market Segment by Applications, can be divided into
    Hospital Pharmacies
    Retail Pharmacies

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports